Palisade Bio (PALI) Invested Capital (2010 - 2026)

Palisade Bio (PALI) has 17 years of Invested Capital data on file, last reported at $127.4 million in Q1 2026.

• Invested Capital for Q1 2026 came in at $127.4 million, up 2258.56% year-over-year; the trailing twelve-month figure through Mar 2026 was $127.4 million (up 2258.56% YoY), and the FY2025 annual result was $129.4 million, up 1626.91% from the prior year.
• Invested Capital declined to $127.4 million in Q1 2026 per PALI's latest filing, from $129.4 million in the prior quarter.
• Over five years, Invested Capital peaked at $129.4 million in Q4 2025 and troughed at $2.7 million in Q2 2025.
• A 5-year average of $23.0 million and a median of $10.2 million in 2024 frame the typical range for Invested Capital.
• The sharpest annual moves came in 2025 and 2026: Invested Capital tumbled 73.4% in 2025, then jumped 2258.56% in 2026.
• A 5-year view of Invested Capital shows it stood at $12.5 million in 2022, then decreased by 8.2% to $11.5 million in 2023, then tumbled by 34.6% to $7.5 million in 2024, then surged by 1626.91% to $129.4 million in 2025, then retreated by 1.56% to $127.4 million in 2026.
• Business Quant data shows PALI's Invested Capital at $127.4 million in Q1 2026, $129.4 million in Q4 2025, and $3.4 million in Q3 2025.